Dr. Michael Braude is a distinguished Gastroenterologist, Hepatologist, and Endoscopy specialist with an extensive medical research and clinical practice background. With an impressive list of qualifications, including BBiomedSc, BSc(Hons), MSc, MBBS, and PhD, he is dedicated to delivering exceptional patient care and advancing medical knowledge. He is a proud fellow of the Royal Australian College of Physicians (FRACP).

Michael’s Journey

Michael’s medical journey began at the University of Melbourne, where he earned his medical degree in 2010. He then completed basic physician training at St. Vincent’s Hospital before advancing to specialised training in Gastroenterology at prestigious institutions like Austin Health, Eastern Health, and Monash Health.

What sets Michael apart is his commitment to research and patient-centric care. In 2022, he completed his PhD through Monash Health and Monash University, focusing on liver disease in marginalised populations. His research, which has been published in local and international peer-reviewed journals, contributes to a deeper understanding of liver health.

When not at work, Michael can be found on a soccer field or with his family, including his three young children.

Clinical Excellence and Special Interests

Dr. Braude’s clinical expertise and interests span various facets of Gastroenterology, including

Check

Liver disease, including Fatty Liver Disease

Check

FibroScan®

Check

Inflammatory bowel disease and bowel cancer screening

Check

Irritable bowel syndrome

Check

Bowel cancer screening

Check

Gastroscopy

Check

Colonoscopy and polypectomy, including endoscopic mucosal resection

Innovative Research and Contributions

His comprehensive research portfolio shows Dr. Braude’s commitment to advancing medical knowledge. He completed his PhD in 2022, with research centred on liver disease in marginalised populations. His work has been published in prestigious peer-reviewed journals and has earned recognition through various awards and scholarships.

Dr. Braude is also a clinical lead in the metabolic fatty liver disease clinic at Monash Health, where he strives to make a difference in patients’ lives. He also leads several international liver clinical trials, demonstrating his dedication to advancing the field of hepatology.

Patient-Centred Approach

With a passion for delivering exceptional patient care, Dr. Braude strongly emphasises effective communication and care. He strives to help individuals achieve their best health potential. He is readily available for urgent appointments within two weeks and can facilitate expedited procedures.

Referring health practitioners can reach out to him directly to discuss patient needs.

Awards and Notable Publications

Dr. Braude’s dedication to research has garnered multiple awards, including the RTP Stipend, Monash Graduate Excellence Scholarship, and more. His significant contributions to medical literature include publications in renowned journals like Psychiatric Services, Clinical Journal of Psychiatry, Hepatology International, and more.

Awards

  • RTP Stipend, Monash University, 2018-2021 
  • Monash Graduate Excellence Scholarship, Monash University, 2018-2021
  • Faculty Postgraduate Excellence Award, Monash University, 2018-2021
  • Clinical Academic Fellowship, Monash Health, 2018-2021
  • Melbourne Research Scholarship, Melbourne University, 2005-2009 
  • Richard Larkins Prize, Melbourne University, 2004 
  • Dean’s Honours List for BSc (Hons), 2004

Publications

  1. Braude M, Roberts S, Majeed A, Lubel J, Prompen J, Dev A, et al. Liver stiffness (Fibroscan (R)) is a predictor of all-cause mortality in people with non-alcoholic fatty liver disease. Liver International. 2023;43(1):90-9. DOI: 10.1111/liv.15415. PMID: 36050821. https://pubmed.ncbi.nlm.nih.gov/36050821/
  2. Braude M, Ratnam D, Marsh L, Abasszade J, Dev A. (2023). Hepatitis C virus treatment with glecaprevir and pibrentasvir in patients co-prescribed carbamazepine: Three case reports. World Journal of Gastrointestinal Pharmacology and Therapeutics. 14. 33-38. 10.4292/wjgpt.v14.i4.33. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359723/ 
  3. Braude M, Phan T, Con D, Woolley I, Sundram S, Clarke D, et al. Hepatitis C virus in people with serious mental illness: an analysis of the care cascade at a tertiary health service with a pilot ‘identify and treat’ strategy. Internal Medicine Journal. 2023;53(5):700-8. DOI: 10.1111/imj.15604. PMID: 34719839 https://pubmed.ncbi.nlm.nih.gov/34719839/ 
  4. Braude M, Khaira G, Woolley I, Clarke D, Dev A, Sievert W. Integrating Hepatitis C Virus Treatment Programs Within Community Mental Health. Psychiatric Services. 2022;73(8):946-9. DOI: 10.1176/appi.ps.202100375. PMID: 34991342 https://pubmed.ncbi.nlm.nih.gov/34991342/ 
  5. Phan T, Low MSY, Low K, Braude M. Thrombocytopenia, splenomegaly, and periportal fibrosis in a migrant. Annals of Hematology. 2022;101(8):1883-4. DOI: 10.1007/s00277-022-04838-3. PMID: 35441857 https://pubmed.ncbi.nlm.nih.gov/35441857/ 
  6. Braude MR, Phan T, Dev A, Sievert W. Determinants of Hepatitis C Virus Prevalence in People With Serious Mental Illness: A Systematic Review and Meta-Analysis. J Clin Psychiatry. 2021;83(1). DOI: 10.4088/JCP.21r14079. PMID: 34905666 https://pubmed.ncbi.nlm.nih.gov/34905666/ 
  7. Braude MR, Con D, Lubel J, Bidwai A, Nguyen HT, Sharmamiglani S, et al. Liver disease prevalence and severity in people with serious mental illness: a cross-sectional analysis using non-invasive diagnostic tools. Hepatol Int. 2021. DOI: 10.1007/s12072-021-10195-6. https://www.ncbi.nlm.nih.gov/pubmed/34081288
  8. Braude MR, Bassily R. Drug-induced liver injury secondary to Scutellaria baicalensis (Chinese skullcap). Intern Med J. 2019;49(4):544-6. DOI: 10.1111/imj.14252. https://www.ncbi.nlm.nih.gov/pubmed/30957370
  9. Braude MR, Con D, Clayton-Chubb D, Nandurkar R, Chua LE, Newnham ED. Acute medical stabilisation of adults with Anorexia Nervosa – experience of a defined interdisciplinary model of care. Intern Med J. 2019. DOI: 10.1111/imj.14329. https://www.ncbi.nlm.nih.gov/pubmed/31059162 
  10. Braude MRH, Newnham ED. Editorial: risk factors for persistent villus atrophy in coeliac disease – is it time to reconsider definitions for refractory coeliac disease? Aliment Pharmacol Ther. 2017;45(11):1477-8. DOI: 10.1111/apt.14055. PMID: 28474827 https://pubmed.ncbi.nlm.nih.gov/28474827/ 
  11. Cao J, Braude M, Mangira D, Nalankilli K, Hou C, Tan M, et al. Risk factors for colorectal surgical resection for non-malignant adenomatous polyps derived from a large Victorian histology database of >4000 colectomy specimens. Journal of Gastroenterology and Hepatology. 2017;32:20-20.
  12. Braude MR, Trubiano JA, Heriot A, Dickinson M, Carney D, Seymour JF, et al. Disseminated visceral varicella zoster virus presenting with the constellation of colonic pseudo-obstruction, acalculous cholecystitis and syndrome of inappropriate ADH secretion. Intern Med J. 2016;46(2):238-9. DOI: 10.1111/imj.12977. PMID: 26899893 https://pubmed.ncbi.nlm.nih.gov/26899893/ 
  13. Khan SA, Thwaites PA, Braude M, Lontos S, Angus PW. Acute oesophageal necrosis. Lancet Gastroenterol Hepatol. 2016;1(1):84. DOI: 10.1016/S2468-1253(16)30025-5. PMID: 28404118 https://pubmed.ncbi.nlm.nih.gov/28404118/ 
  14. Braude M, Choong P. An incidentaloma not to be missed. Med J Aust. 2015;202(6):308. DOI: 10.5694/mja15.00221. PMID: 25832154 https://www.mja.com.au/journal/2015/202/6/incidentaloma-not-be-missed

Book an appointment

Contact us for appointments and enquiries. Dr. Braude’s commitment to delivering exceptional care and his expertise in Gastroenterology and Hepatology make him a trusted healthcare partner.